Edition:
United Kingdom

JCR Pharmaceuticals Co Ltd (4552.T)

4552.T on Tokyo Stock Exchange

5,890JPY
20 Jul 2018
Change (% chg)

¥-70 (-1.17%)
Prev Close
¥5,960
Open
¥5,980
Day's High
¥6,090
Day's Low
¥5,860
Volume
148,500
Avg. Vol
138,988
52-wk High
¥7,350
52-wk Low
¥2,828

Summary

Name Age Since Current Position

Shin Ashida

70 2007 Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer, Chairman of Subsidiary, Representative Director

Hiroshi Yoshimoto

66 2018 Senior Managing Director, Chief Director of Production, Representative Director

Mamoru Morita

Executive Director

Yoshihiko Ohnishi

2016 Executive Officer, Chief Director of Sales, Director of Eastern Japan Sales

Norihiko Shibue

2013 Executive Officer, Deputy Chief Director of Sales

Takayo Egawa

2018 Executive Officer, Manager of Overseas Business Promotion Office

Akihiro Haguchi

2017 Executive Officer, Chief Director of Administration

Toru Hirato

2018 Executive Officer, Chief Director of Research, Director of Research

Yutaka Honda

2016 Executive Officer, Chief Director of Business Planning

Yuichi Miura

2012 Executive Officer, Director of General Affairs in Main Administration Unit

Toru Ashida

2018 Manager of President's Office, Director

Yuji Sato

2018 Chief Director of Development, Director

Yuko Hayashi

2018 Independent Director

Toshihiro Ishikiriyama

65 2015 Independent Director

Takashi Suetsuna

2017 Independent Director

Shunjiro Sugimoto

63 2010 Independent Director

Toshihide Yoda

55 2018 Independent Director

Biographies

Name Description

Shin Ashida

Mr. Shin Ashida has been serving as Chairman of the Board, President, Chief Executive Officer, Chief Operating Officer and Representative Director in JCR Pharmaceuticals Co., Ltd., as well as Chairman in a China-based subsidiary since June 2007. He established the Company in September 1975. He previously worked for a Japan-based company, as well as served as Representative Director in another company.

Hiroshi Yoshimoto

Mr. Hiroshi Yoshimoto was named Senior Managing Director, Chief Director of Production and Representative Director in JCR Pharmaceuticals Co., Ltd. effective June 2018. He joined the Company in March 2011. He used to work for a company that now is Pfizer Japan Inc.

Mamoru Morita

Yoshihiko Ohnishi

Norihiko Shibue

Takayo Egawa

Akihiro Haguchi

Toru Hirato

Yutaka Honda

Yuichi Miura

Toru Ashida

Mr. Toru Ashida was named Manager of President's Office and Director in JCR Pharmaceuticals Co., Ltd. effective June 2018. He joined the Company in January 2014. His previous titles include Executive Officer, Chief Director of Business Support and Director of Business Strategy in the Company. He used to work for Nippon Life Insurance Company and JBS Logistics Service, Inc.

Yuji Sato

Mr. Yuji Sato was named Chief Director of Development and Director in JCR Pharmaceuticals Co., Ltd. effective June 2018. He joined the Company in December 2017. He previously served as Executive Officer in the Company. He used to work for MSD K.K. and Sanofi K.K.

Yuko Hayashi

Ms. Yuko Hayashi was named Independent Director in JCR Pharmaceuticals Co., Ltd. effective June 2018. She is also working for The University of Tokyo. She is also a Specially Appointed Professor of Yamaguchi University. She used to work for IBM Japan, Ltd.

Toshihiro Ishikiriyama

Takashi Suetsuna

Mr. Takashi Suetsuna was named Independent Director in JCR Pharmaceuticals Co., Ltd. effective June 2017. He is also serving as Independent Director in TOTETSU KOGYO CO., LTD., and working for Marubeni Corporation, Kandenko Company, Limited and Keikyu Corporation.

Shunjiro Sugimoto

Mr. Shunjiro Sugimoto has been serving as Independent Director of JCR Pharmaceuticals Co., Ltd. since June 2010. He is also serving as Director of GlaxoSmithKline K.K. He used to work for The Chemo-Sero-Therapeutic Research Institute and two other companies.

Toshihide Yoda

Mr. Toshihide Yoda was named Independent Director in JCR Pharmaceuticals Co., Ltd. effective June 2018. He is also serving as Managing Director, Chief Director of Business Development and Director of Business Development in Business Development Unit in Medipal Holdings Corporation, as well as Director in SPLine Corporation, Medie Co., Ltd., MEDICEO CORPORATION and JCR USA, Inc. He used to work for other five companies, including Mizuho Investors Securities Co., Ltd., UBS Securities Japan Co., Ltd. and Lehman Brothers Securities Japan Co., Ltd.